
Novartis AG has announced a $23 billion investment in U.S.
(20 second reading) In a major move toward localized manufacturing, Swiss pharma giant Novartis AG has announced a $23 billion investment to expand its U.S. operations over the next five years. The plan includes building 10 facilities—seven of them new—and is expected to create 1,000 direct jobs at Novartis and around 4,000 additional jobs nationwide. This initiative aligns with the industry’s shift in response to anticipated U.S. regulatory changes.
Quicklinks